retatrutide parkinson's disease trial nct The NADPARK study: A randomized phase I of nicotinamide riboside supplementation in Current Therapies in Clinical Trials – retatrutide parkinson's disease clinical trial
Pay in 4 interest-free payments of $7.19 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 4 - Oct 9






















